Semi-Blind and l1 Robust System Identification for Anemia Management
Affan Affan, Tamer Inanc

TL;DR
This paper develops and compares two robust system identification methods for personalized anemia management in CKD patients, demonstrating that semi-blind identification outperforms l1 in modeling drug-response dynamics.
Contribution
It introduces a semi-blind robust system identification approach for individualized drug response modeling in CKD anemia management, improving accuracy over existing methods.
Findings
Semi-blind identification yields lower MMSE than l1 method.
Patient-specific models improve drug response prediction.
The approach enhances personalized treatment strategies.
Abstract
Chronic diseases such as cancer, diabetes, heart diseases, chronic kidney disease (CKD) require a drug management system that ensures a stable and robust output of the patient's condition in response to drug dosage. In the case of CKD, the patients suffer from the deficiency of red blood cell count and external human recombinant erythropoietin (EPO) is required to maintain healthy levels of hemoglobin (Hb). Anemia is a common comorbidity in patients with CKD. For an efficient and robust anemia management system for CKD patients instead of traditional population-based approaches, individualized patient-specific approaches are needed. Hence, individualized system (patient) models for patient-specific drug-dose responses are required. In this research, system identification for CKD is performed for individual patients. For control-oriented system identification, two robust identification…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsControl Systems and Identification · Fault Detection and Control Systems · Gaussian Processes and Bayesian Inference
